Cancer therapies can cause significant skin, scalp, and nail side effects in nearly two-thirds of patients, impacting comfort ...

A study has found that the incidence of inflammatory skin diseases is higher in affluent regions. According to the New York ...

Autoimmune diseases are rising in India. Experts explain why cases are increasing, the early symptoms people miss, key ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...

Even as the prevalence of psoriasis increases around the world, with the highest proportions found in white populations, there is apparently a greater burden of disease among populations with skin of ...

Psoriasis cases globally have nearly doubled from 1990 to 2021, reaching an estimated 43 million cases and 5.1 million new diagnoses in 2021. Global psoriasis cases nearly doubled from 2.85 million in ...

Psoriasis is a chronic autoimmune skin condition causing red, scaly patches. It can appear on various body parts, including the scalp, elbows, knees, hands, feet, lower back, torso, face, and ...

Each August, Psoriasis Awareness Month shines a light on a condition affecting millions worldwide. This special time helps people understand psoriasis better. It also builds vital support for ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

May 9 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily pill helped patients achieve clear ...